Share Price and Basic Stock Data
Last Updated: February 9, 2026, 10:17 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Elixir Capital Ltd, operating in the Finance & Investments sector, reported a market capitalization of ₹61.2 Cr with a share price of ₹105. The company has experienced significant fluctuations in its revenue, with sales standing at ₹4.32 Cr for the fiscal year ending March 2023, a notable decrease from ₹24.53 Cr in March 2022. However, there appears to be a recovery trajectory, as sales for the fiscal year ending March 2024 are reported at ₹34.63 Cr, further projected to rise to ₹36.07 Cr in March 2025. Quarterly sales data shows a volatile pattern, with a peak of ₹15.81 Cr in March 2024, suggesting that the company is navigating through a recovery phase. The trailing twelve months (TTM) revenue stood at ₹24.09 Cr, reflecting the ongoing challenges in maintaining stable revenue inflows. This revenue volatility emphasizes the importance of strategic operational adjustments to enhance revenue stability in a competitive market.
Profitability and Efficiency Metrics
Elixir Capital’s profitability metrics indicate a mixed performance. The company recorded a net profit of ₹-1.25 Cr for the latest fiscal year, contrasting sharply with net profits of ₹20.96 Cr and ₹12.99 Cr in March 2024 and March 2022, respectively. The operating profit margin (OPM) was reported at 40.31%, which, while relatively strong, has shown fluctuations across quarters, with a high of 84.76% in March 2024 and a low of -1,537.50% in December 2022. The return on equity (ROE) stood at 18.0%, while the return on capital employed (ROCE) was at 20.1%. These figures suggest that while the company is generating decent returns on its investments, the profitability challenges highlighted by the negative net profit indicate areas for operational efficiency improvements. The interest coverage ratio (ICR) of 10.26x further reflects the company’s ability to meet its interest obligations comfortably.
Balance Sheet Strength and Financial Ratios
Elixir Capital’s balance sheet reflects a growing financial base, with total assets reported at ₹115.59 Cr for the fiscal year ending March 2025, a significant increase from ₹67.53 Cr in March 2023. The company’s reserves stood at ₹54.42 Cr, while borrowings increased to ₹38.22 Cr, suggesting a strategic leveraging of debt to foster growth. The debt-to-equity ratio of 0.55 indicates a moderate level of financial leverage, which is manageable given the company’s equity capital of ₹5.80 Cr. Additionally, the current ratio of 2.37 signifies strong liquidity, enabling the company to cover its short-term obligations effectively. The price-to-book value ratio (P/BV) of 1.38x indicates that the stock is trading at a premium compared to its book value, which could reflect investor confidence in its growth potential despite recent profitability challenges.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Elixir Capital Ltd reveals a strong promoter holding of 71.29%, suggesting substantial insider confidence in the company’s prospects. The public shareholding is reported at 28.72%, with a total of 4,227 shareholders as of September 2025. This distribution indicates a stable ownership structure, with the promoters maintaining a majority stake, which can be a positive signal for potential investors. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) raises questions about broader market confidence in the stock. The recent increase in the number of shareholders from 3,516 in December 2022 to 4,227 in September 2025 may suggest growing interest from retail investors, potentially driven by the recent recovery in sales and profitability metrics.
Outlook, Risks, and Final Insight
The outlook for Elixir Capital appears cautiously optimistic, given the recovery in sales and profitability metrics. However, the volatility in revenue and the negative net profit reported indicate significant operational risks that need to be addressed. Potential strengths include a solid promoter backing and a healthy liquidity position, which could facilitate strategic investments for growth. Conversely, the reliance on debt financing and the lack of institutional investor participation may pose risks to long-term stability. Future scenarios could involve continued revenue growth if operational efficiencies are improved and market conditions remain favorable. Conversely, any downturn in economic conditions or operational missteps could exacerbate existing profitability challenges, necessitating vigilant management and strategic adjustments.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.4 Cr. | 38.7 | 54.5/36.1 | 54.0 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,395 Cr. | 302 | 406/265 | 14.9 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 32.3 Cr. | 0.46 | 0.92/0.38 | 4.48 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 3.95 Cr. | 7.98 | 11.6/7.58 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 12.6 Cr. | 24.5 | 69.9/24.5 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,407.52 Cr | 1,254.68 | 70.57 | 4,367.27 | 0.37% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.80 | 0.08 | -0.60 | 4.75 | 6.09 | 5.91 | 15.81 | 14.72 | 18.56 | 6.04 | -3.96 | 10.92 | 11.09 |
| Expenses | 1.53 | 1.31 | 1.51 | 1.57 | 1.68 | 1.62 | 2.41 | 3.04 | 3.00 | 3.70 | 5.59 | 6.67 | 6.62 |
| Operating Profit | 6.27 | -1.23 | -2.11 | 3.18 | 4.41 | 4.29 | 13.40 | 11.68 | 15.56 | 2.34 | -9.55 | 4.25 | 4.47 |
| OPM % | 80.38% | -1,537.50% | 66.95% | 72.41% | 72.59% | 84.76% | 79.35% | 83.84% | 38.74% | 38.92% | 40.31% | ||
| Other Income | 0.05 | 0.17 | 0.24 | 0.34 | 0.89 | 0.22 | 1.20 | 0.27 | 0.16 | 0.22 | -0.13 | 1.17 | 0.09 |
| Interest | 0.28 | 0.33 | 0.30 | 0.34 | 0.40 | 0.33 | 0.45 | 0.43 | 0.56 | 0.66 | 0.38 | 0.62 | 0.59 |
| Depreciation | 0.08 | 0.08 | 0.10 | 0.08 | 0.09 | 0.08 | 0.09 | 0.07 | 0.09 | 0.08 | 0.26 | 0.11 | 0.11 |
| Profit before tax | 5.96 | -1.47 | -2.27 | 3.10 | 4.81 | 4.10 | 14.06 | 11.45 | 15.07 | 1.82 | -10.32 | 4.69 | 3.86 |
| Tax % | 6.04% | -2.72% | 16.74% | 1.61% | 15.38% | 22.44% | 24.32% | 24.98% | 25.08% | 34.62% | -18.22% | 21.54% | 39.90% |
| Net Profit | 5.61 | -1.43 | -2.65 | 3.06 | 4.08 | 3.19 | 10.63 | 8.59 | 11.30 | 1.19 | -8.44 | 3.69 | 2.31 |
| EPS in Rs | 28.98 | -1.77 | -3.38 | 3.89 | 5.39 | 4.07 | 13.54 | 10.94 | 14.41 | 1.52 | -10.80 | 4.70 | 2.95 |
Last Updated: December 27, 2025, 3:05 am
Below is a detailed analysis of the quarterly data for Elixir Capital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 11.09 Cr.. The value appears strong and on an upward trend. It has increased from 10.92 Cr. (Jun 2025) to 11.09 Cr., marking an increase of 0.17 Cr..
- For Expenses, as of Sep 2025, the value is 6.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.67 Cr. (Jun 2025) to 6.62 Cr., marking a decrease of 0.05 Cr..
- For Operating Profit, as of Sep 2025, the value is 4.47 Cr.. The value appears strong and on an upward trend. It has increased from 4.25 Cr. (Jun 2025) to 4.47 Cr., marking an increase of 0.22 Cr..
- For OPM %, as of Sep 2025, the value is 40.31%. The value appears strong and on an upward trend. It has increased from 38.92% (Jun 2025) to 40.31%, marking an increase of 1.39%.
- For Other Income, as of Sep 2025, the value is 0.09 Cr.. The value appears to be declining and may need further review. It has decreased from 1.17 Cr. (Jun 2025) to 0.09 Cr., marking a decrease of 1.08 Cr..
- For Interest, as of Sep 2025, the value is 0.59 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.62 Cr. (Jun 2025) to 0.59 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Sep 2025, the value is 0.11 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.11 Cr..
- For Profit before tax, as of Sep 2025, the value is 3.86 Cr.. The value appears to be declining and may need further review. It has decreased from 4.69 Cr. (Jun 2025) to 3.86 Cr., marking a decrease of 0.83 Cr..
- For Tax %, as of Sep 2025, the value is 39.90%. The value appears to be increasing, which may not be favorable. It has increased from 21.54% (Jun 2025) to 39.90%, marking an increase of 18.36%.
- For Net Profit, as of Sep 2025, the value is 2.31 Cr.. The value appears to be declining and may need further review. It has decreased from 3.69 Cr. (Jun 2025) to 2.31 Cr., marking a decrease of 1.38 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.95. The value appears to be declining and may need further review. It has decreased from 4.70 (Jun 2025) to 2.95, marking a decrease of 1.75.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:47 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.86 | 11.70 | 4.45 | 12.41 | 10.15 | 3.70 | -0.40 | 19.62 | 24.53 | 4.32 | 34.63 | 36.07 | 24.09 |
| Expenses | 1.71 | 1.81 | 2.26 | 2.64 | 3.76 | 3.36 | 3.73 | 4.61 | 5.53 | 5.70 | 7.25 | 15.33 | 22.58 |
| Operating Profit | 2.15 | 9.89 | 2.19 | 9.77 | 6.39 | 0.34 | -4.13 | 15.01 | 19.00 | -1.38 | 27.38 | 20.74 | 1.51 |
| OPM % | 55.70% | 84.53% | 49.21% | 78.73% | 62.96% | 9.19% | 76.50% | 77.46% | -31.94% | 79.06% | 57.50% | 6.27% | |
| Other Income | 0.00 | 0.00 | 1.54 | 0.04 | 0.10 | 0.06 | 0.05 | 0.02 | 0.03 | 0.18 | 0.56 | -0.19 | 1.35 |
| Interest | 0.06 | 0.05 | 0.07 | 0.13 | 0.15 | 0.25 | 0.19 | 0.95 | 1.66 | 1.13 | 1.52 | 2.03 | 2.25 |
| Depreciation | 0.50 | 0.47 | 0.46 | 0.48 | 0.47 | 0.45 | 0.40 | 0.41 | 0.37 | 0.34 | 0.34 | 0.50 | 0.56 |
| Profit before tax | 1.59 | 9.37 | 3.20 | 9.20 | 5.87 | -0.30 | -4.67 | 13.67 | 17.00 | -2.67 | 26.08 | 18.02 | 0.05 |
| Tax % | 29.56% | 29.35% | 24.38% | 25.00% | 28.28% | -10.00% | 10.49% | 10.53% | 23.65% | 28.46% | 19.63% | 29.86% | |
| Net Profit | 1.11 | 6.61 | 2.41 | 6.90 | 4.21 | -0.21 | -3.83 | 12.22 | 12.99 | -3.43 | 20.96 | 12.65 | -1.25 |
| EPS in Rs | 1.40 | 8.43 | 2.89 | 11.89 | 5.36 | -0.36 | -6.60 | 15.72 | 16.54 | -5.91 | 26.90 | 16.08 | -1.63 |
| Dividend Payout % | 121.31% | 20.16% | 11.74% | 10.51% | 23.31% | -345.24% | -18.93% | 7.95% | 7.55% | -21.14% | 4.64% | 7.77% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 495.50% | -63.54% | 186.31% | -38.99% | -104.99% | -1723.81% | 419.06% | 6.30% | -126.40% | 711.08% | -39.65% |
| Change in YoY Net Profit Growth (%) | 0.00% | -559.04% | 249.85% | -225.29% | -66.00% | -1618.82% | 2142.87% | -412.76% | -132.71% | 837.48% | -750.73% |
Elixir Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | % |
| 3 Years: | 14% |
| TTM: | -26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 35% |
| 3 Years: | 0% |
| TTM: | -69% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 30% |
| 3 Years: | 39% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 21% |
| 3 Years: | 17% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 3:21 pm
Balance Sheet
Last Updated: December 4, 2025, 2:49 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.78 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 |
| Reserves | 9.70 | 13.44 | 13.93 | 17.63 | 21.16 | 19.76 | 14.71 | 22.83 | 31.44 | 28.01 | 42.63 | 50.97 | 54.42 |
| Borrowings | 1.54 | 0.57 | 1.95 | 1.72 | 1.59 | 1.22 | 1.24 | 17.44 | 17.68 | 7.34 | 23.60 | 31.32 | 38.22 |
| Other Liabilities | 6.73 | 8.54 | 8.39 | 11.22 | 11.68 | 11.71 | 16.75 | 26.76 | 27.72 | 26.38 | 24.36 | 27.50 | 29.60 |
| Total Liabilities | 23.75 | 28.35 | 30.07 | 36.37 | 40.23 | 38.49 | 38.50 | 72.83 | 82.64 | 67.53 | 96.39 | 115.59 | 128.04 |
| Fixed Assets | 5.84 | 5.67 | 5.30 | 4.75 | 4.87 | 4.54 | 4.20 | 3.93 | 3.69 | 3.54 | 3.26 | 3.64 | 3.51 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.19 | 0.71 | 0.83 | 0.00 | 0.00 | 0.00 | 9.91 | 12.51 | 11.93 | 11.07 | 12.24 | 17.96 | 18.10 |
| Other Assets | 16.72 | 21.97 | 23.94 | 31.62 | 35.36 | 33.95 | 24.39 | 56.39 | 67.02 | 52.92 | 80.89 | 93.99 | 106.43 |
| Total Assets | 23.75 | 28.35 | 30.07 | 36.37 | 40.23 | 38.49 | 38.50 | 72.83 | 82.64 | 67.53 | 96.39 | 115.59 | 128.04 |
Below is a detailed analysis of the balance sheet data for Elixir Capital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.80 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.80 Cr..
- For Reserves, as of Sep 2025, the value is 54.42 Cr.. The value appears strong and on an upward trend. It has increased from 50.97 Cr. (Mar 2025) to 54.42 Cr., marking an increase of 3.45 Cr..
- For Borrowings, as of Sep 2025, the value is 38.22 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 31.32 Cr. (Mar 2025) to 38.22 Cr., marking an increase of 6.90 Cr..
- For Other Liabilities, as of Sep 2025, the value is 29.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.50 Cr. (Mar 2025) to 29.60 Cr., marking an increase of 2.10 Cr..
- For Total Liabilities, as of Sep 2025, the value is 128.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 115.59 Cr. (Mar 2025) to 128.04 Cr., marking an increase of 12.45 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3.51 Cr.. The value appears to be declining and may need further review. It has decreased from 3.64 Cr. (Mar 2025) to 3.51 Cr., marking a decrease of 0.13 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 18.10 Cr.. The value appears strong and on an upward trend. It has increased from 17.96 Cr. (Mar 2025) to 18.10 Cr., marking an increase of 0.14 Cr..
- For Other Assets, as of Sep 2025, the value is 106.43 Cr.. The value appears strong and on an upward trend. It has increased from 93.99 Cr. (Mar 2025) to 106.43 Cr., marking an increase of 12.44 Cr..
- For Total Assets, as of Sep 2025, the value is 128.04 Cr.. The value appears strong and on an upward trend. It has increased from 115.59 Cr. (Mar 2025) to 128.04 Cr., marking an increase of 12.45 Cr..
Notably, the Reserves (54.42 Cr.) exceed the Borrowings (38.22 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.61 | 9.32 | 0.24 | 8.05 | 4.80 | -0.88 | -5.37 | -2.43 | 1.32 | -8.72 | 3.78 | -10.58 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 8.51 | 0.00 | 0.82 | 3.24 | 5.75 | 1.97 | -2,646.25 | 0.37 | 5.21 | 21.12 | 2.42 | 0.81 |
| Inventory Days | -7,418.62 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 8.51 | 0.00 | 0.82 | 3.24 | 5.75 | 1.97 | -10,064.88 | 0.37 | 5.21 | 21.12 | 2.42 | 0.81 |
| Working Capital Days | 748.91 | 442.37 | 1,232.80 | 648.53 | 929.94 | 2,434.65 | 3,102.50 | 388.25 | 431.07 | 1,684.75 | 598.25 | 697.42 |
| ROCE % | 7.44% | 38.27% | 6.27% | 29.05% | 16.35% | -0.13% | -13.23% | 32.98% | 29.06% | -2.45% | 36.75% | 20.07% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 16.07 | 26.89 | -4.20 | 16.54 | 15.72 |
| Diluted EPS (Rs.) | 16.07 | 26.89 | -4.20 | 16.54 | 15.72 |
| Cash EPS (Rs.) | 22.64 | 36.70 | -5.32 | 23.00 | 21.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 97.83 | 117.55 | 83.14 | 90.74 | 70.07 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 97.83 | 117.55 | 83.14 | 90.74 | 70.07 |
| Revenue From Operations / Share (Rs.) | 60.94 | 56.07 | 6.48 | 39.92 | 33.12 |
| PBDIT / Share (Rs.) | 35.96 | 47.25 | -2.06 | 32.80 | 25.90 |
| PBIT / Share (Rs.) | 35.10 | 46.67 | -2.64 | 32.17 | 25.19 |
| PBT / Share (Rs.) | 31.06 | 44.94 | -4.59 | 29.30 | 23.55 |
| Net Profit / Share (Rs.) | 21.78 | 36.11 | -5.90 | 22.37 | 21.07 |
| NP After MI And SOA / Share (Rs.) | 16.07 | 26.89 | -4.20 | 16.54 | 15.72 |
| PBDIT Margin (%) | 59.00 | 84.27 | -31.82 | 82.16 | 78.20 |
| PBIT Margin (%) | 57.60 | 83.23 | -40.75 | 80.58 | 76.05 |
| PBT Margin (%) | 50.95 | 80.14 | -70.85 | 73.40 | 71.10 |
| Net Profit Margin (%) | 35.74 | 64.40 | -91.11 | 56.04 | 63.62 |
| NP After MI And SOA Margin (%) | 26.37 | 47.96 | -64.80 | 41.42 | 47.47 |
| Return on Networth / Equity (%) | 16.42 | 32.22 | -7.20 | 25.76 | 31.86 |
| Return on Capital Employeed (%) | 25.40 | 39.68 | -3.17 | 35.43 | 35.89 |
| Return On Assets (%) | 8.06 | 16.19 | -3.60 | 11.61 | 12.52 |
| Total Debt / Equity (X) | 0.55 | 0.48 | 0.21 | 0.47 | 0.60 |
| Asset Turnover Ratio (%) | 0.33 | 0.39 | 0.05 | 0.29 | 0.34 |
| Current Ratio (X) | 2.37 | 2.52 | 2.81 | 2.31 | 1.91 |
| Quick Ratio (X) | 0.70 | 0.58 | 1.20 | 0.95 | 0.82 |
| Inventory Turnover Ratio (X) | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 10.59 | 6.32 | -40.54 | 10.29 | 11.05 |
| Dividend Payout Ratio (CP) (%) | 10.05 | 6.19 | -47.02 | 9.91 | 10.58 |
| Earning Retention Ratio (%) | 89.41 | 93.68 | 140.54 | 89.71 | 88.95 |
| Cash Earning Retention Ratio (%) | 89.95 | 93.81 | 147.02 | 90.09 | 89.42 |
| Interest Coverage Ratio (X) | 10.26 | 18.02 | -1.06 | 11.44 | 15.81 |
| Interest Coverage Ratio (Post Tax) (X) | 7.37 | 14.43 | -2.03 | 8.80 | 13.86 |
| Enterprise Value (Cr.) | 121.71 | 85.03 | 30.51 | 39.19 | 32.72 |
| EV / Net Operating Revenue (X) | 3.44 | 2.61 | 8.11 | 1.69 | 1.70 |
| EV / EBITDA (X) | 5.83 | 3.10 | -25.50 | 2.06 | 2.18 |
| MarketCap / Net Operating Revenue (X) | 2.21 | 1.58 | 5.28 | 0.95 | 0.86 |
| Retention Ratios (%) | 89.40 | 93.67 | 140.54 | 89.70 | 88.94 |
| Price / BV (X) | 1.38 | 1.06 | 0.58 | 0.59 | 0.57 |
| Price / Net Operating Revenue (X) | 2.21 | 1.58 | 5.28 | 0.95 | 0.86 |
| EarningsYield | 0.11 | 0.30 | -0.12 | 0.43 | 0.54 |
After reviewing the key financial ratios for Elixir Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 16.07. This value is within the healthy range. It has decreased from 26.89 (Mar 24) to 16.07, marking a decrease of 10.82.
- For Diluted EPS (Rs.), as of Mar 25, the value is 16.07. This value is within the healthy range. It has decreased from 26.89 (Mar 24) to 16.07, marking a decrease of 10.82.
- For Cash EPS (Rs.), as of Mar 25, the value is 22.64. This value is within the healthy range. It has decreased from 36.70 (Mar 24) to 22.64, marking a decrease of 14.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 97.83. It has decreased from 117.55 (Mar 24) to 97.83, marking a decrease of 19.72.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 97.83. It has decreased from 117.55 (Mar 24) to 97.83, marking a decrease of 19.72.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 60.94. It has increased from 56.07 (Mar 24) to 60.94, marking an increase of 4.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 35.96. This value is within the healthy range. It has decreased from 47.25 (Mar 24) to 35.96, marking a decrease of 11.29.
- For PBIT / Share (Rs.), as of Mar 25, the value is 35.10. This value is within the healthy range. It has decreased from 46.67 (Mar 24) to 35.10, marking a decrease of 11.57.
- For PBT / Share (Rs.), as of Mar 25, the value is 31.06. This value is within the healthy range. It has decreased from 44.94 (Mar 24) to 31.06, marking a decrease of 13.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 21.78. This value is within the healthy range. It has decreased from 36.11 (Mar 24) to 21.78, marking a decrease of 14.33.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 16.07. This value is within the healthy range. It has decreased from 26.89 (Mar 24) to 16.07, marking a decrease of 10.82.
- For PBDIT Margin (%), as of Mar 25, the value is 59.00. This value is within the healthy range. It has decreased from 84.27 (Mar 24) to 59.00, marking a decrease of 25.27.
- For PBIT Margin (%), as of Mar 25, the value is 57.60. This value exceeds the healthy maximum of 20. It has decreased from 83.23 (Mar 24) to 57.60, marking a decrease of 25.63.
- For PBT Margin (%), as of Mar 25, the value is 50.95. This value is within the healthy range. It has decreased from 80.14 (Mar 24) to 50.95, marking a decrease of 29.19.
- For Net Profit Margin (%), as of Mar 25, the value is 35.74. This value exceeds the healthy maximum of 10. It has decreased from 64.40 (Mar 24) to 35.74, marking a decrease of 28.66.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 26.37. This value exceeds the healthy maximum of 20. It has decreased from 47.96 (Mar 24) to 26.37, marking a decrease of 21.59.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.42. This value is within the healthy range. It has decreased from 32.22 (Mar 24) to 16.42, marking a decrease of 15.80.
- For Return on Capital Employeed (%), as of Mar 25, the value is 25.40. This value is within the healthy range. It has decreased from 39.68 (Mar 24) to 25.40, marking a decrease of 14.28.
- For Return On Assets (%), as of Mar 25, the value is 8.06. This value is within the healthy range. It has decreased from 16.19 (Mar 24) to 8.06, marking a decrease of 8.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.55. This value is within the healthy range. It has increased from 0.48 (Mar 24) to 0.55, marking an increase of 0.07.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has decreased from 0.39 (Mar 24) to 0.33, marking a decrease of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 2.37. This value is within the healthy range. It has decreased from 2.52 (Mar 24) to 2.37, marking a decrease of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.70, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.62, marking an increase of 0.62.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.59. This value is below the healthy minimum of 20. It has increased from 6.32 (Mar 24) to 10.59, marking an increase of 4.27.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 10.05. This value is below the healthy minimum of 20. It has increased from 6.19 (Mar 24) to 10.05, marking an increase of 3.86.
- For Earning Retention Ratio (%), as of Mar 25, the value is 89.41. This value exceeds the healthy maximum of 70. It has decreased from 93.68 (Mar 24) to 89.41, marking a decrease of 4.27.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 89.95. This value exceeds the healthy maximum of 70. It has decreased from 93.81 (Mar 24) to 89.95, marking a decrease of 3.86.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 10.26. This value is within the healthy range. It has decreased from 18.02 (Mar 24) to 10.26, marking a decrease of 7.76.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.37. This value is within the healthy range. It has decreased from 14.43 (Mar 24) to 7.37, marking a decrease of 7.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 121.71. It has increased from 85.03 (Mar 24) to 121.71, marking an increase of 36.68.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.44. This value exceeds the healthy maximum of 3. It has increased from 2.61 (Mar 24) to 3.44, marking an increase of 0.83.
- For EV / EBITDA (X), as of Mar 25, the value is 5.83. This value is within the healthy range. It has increased from 3.10 (Mar 24) to 5.83, marking an increase of 2.73.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 2.21, marking an increase of 0.63.
- For Retention Ratios (%), as of Mar 25, the value is 89.40. This value exceeds the healthy maximum of 70. It has decreased from 93.67 (Mar 24) to 89.40, marking a decrease of 4.27.
- For Price / BV (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has increased from 1.06 (Mar 24) to 1.38, marking an increase of 0.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 2.21, marking an increase of 0.63.
- For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.30 (Mar 24) to 0.11, marking a decrease of 0.19.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Elixir Capital Ltd:
- Net Profit Margin: 35.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.4% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.42% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 7.37
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.7
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 70.57)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.55
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 35.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 58, Mittal Chambers, Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dipan Mehta | Chairman |
| Mrs. Radhika Mehta | Whole Time Director |
| Mrs. Manori Shah | Independent Director |
| Mr. Shail Kapadia | Independent Director |
FAQ
What is the intrinsic value of Elixir Capital Ltd?
Elixir Capital Ltd's intrinsic value (as of 10 February 2026) is ₹125.91 which is 18.78% higher the current market price of ₹106.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹61.4 Cr. market cap, FY2025-2026 high/low of ₹235/91.8, reserves of ₹54.42 Cr, and liabilities of ₹128.04 Cr.
What is the Market Cap of Elixir Capital Ltd?
The Market Cap of Elixir Capital Ltd is 61.4 Cr..
What is the current Stock Price of Elixir Capital Ltd as on 10 February 2026?
The current stock price of Elixir Capital Ltd as on 10 February 2026 is ₹106.
What is the High / Low of Elixir Capital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Elixir Capital Ltd stocks is ₹235/91.8.
What is the Stock P/E of Elixir Capital Ltd?
The Stock P/E of Elixir Capital Ltd is .
What is the Book Value of Elixir Capital Ltd?
The Book Value of Elixir Capital Ltd is 104.
What is the Dividend Yield of Elixir Capital Ltd?
The Dividend Yield of Elixir Capital Ltd is 1.18 %.
What is the ROCE of Elixir Capital Ltd?
The ROCE of Elixir Capital Ltd is 20.1 %.
What is the ROE of Elixir Capital Ltd?
The ROE of Elixir Capital Ltd is 18.0 %.
What is the Face Value of Elixir Capital Ltd?
The Face Value of Elixir Capital Ltd is 10.0.